USPTO trademark

CYCLACEL

RegisteredUSPTOWord markClass 5Class 42

"CYCLACEL" is a word mark owned by Cyclacel Limited, filed at the USPTO on September 29, 2022. It is registered and covers classes 5 and 42.

Official USPTO record
CYCLACEL trademark as filed
As filed with the USPTO
Status
Registered
Since February 6, 2024
Filed
September 29, 2022
Registered
February 6, 2024
Expires
Not recorded
Application no.
97613039
Registration no.
7297048
Office
USPTO
United States Patent and Trademark Office
Mark type
Word mark
2 classes
Ownership

Who owns CYCLACEL

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

Cyclacel Limited

London, United Kingdom

47 trademarks in the portfolioView company

Representative

Jeffrey A. Smith

Millen, White, Zelano & Branigan, P.C.

Goods and services

What the mark covers

The products and services CYCLACEL is filed for, grouped by Nice class.

  • Pharmaceutical products for the treatment of cancer; pharmaceutical preparations for the treatment of cancer; pharmaceutical substances and preparations for the treatment of cancer, hematological disorders; pharmaceutical substances and preparations for use in oncology, hematology; medical preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of oncological diseases and preparations for use in oncology; medicinal preparations for the treatment of cancer and hematological disorders; medical substances in the nature of pharmaceuticals for the treatment of cancer and hematological disorders; pharmaceutical preparations for human use for the treatment of cancer and hematological disorders

  • Research services and laboratory research services in the nature of pharmaceutical development, pharmaceutical products development, development of pharmaceuticals for the treatment of cancer, development of products for the treatment of cancer, development of pharmaceuticals for the treatment of leukemia, development of pharmaceuticals for the treatment of hematological cancers, development of products for the treatment of leukemia, and development of products for the treatment of hematological cancers

History

What has happened so far

Steps recorded by the USPTO, newest first.

  1. Notice of registration confirmation emailed
  2. Registered-principal register
  3. Official gazette publication confirmation e-mailed
  4. Published for opposition
  5. Notification of notice of publication e-mailed
  6. Approved for pub - principal register
  7. Examiner's amendment entered
  8. Notification of examiners amendment e-mailed
  9. Examiners amendment e-mailed
  10. Examiners amendment -written

6 earlier steps on the official record.

FAQ

About CYCLACEL

Who owns the trademark "CYCLACEL"?

The USPTO trademark "CYCLACEL" (application 97613039) is owned by Cyclacel Limited.

What is the status of "CYCLACEL"?

Its status at the USPTO is: registered.

When was "CYCLACEL" registered?

It was registered on February 6, 2024.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull CYCLACEL and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

GET /v1/trademarks/{id}
ID=tm_019d2afb-b350-70be-afe7-c582a8f72910
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_019d2afb-b350-70be-afe7-c582a8f72910",
  "object": "trademark",
  "mark_text": "CYCLACEL",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "US",
  "application_number": "97613039",
  "filing_date": "2022-09-29",
  "nice_classes": [
    5,
    42
  ],
  "owners": [
    {
      "name": "Cyclacel Limited",
      "entity_id": "ent_019eb7b0-b5af-7019-bad7-bd0dd326b3fc"
    }
  ]
}